Patents by Inventor Gary J. Beck

Gary J. Beck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination of brimonidine and timolol for topical ophthalmic use
    Patent number: 7320976
    Abstract: Disclosed are pharmaceutical compositions comprising brimondine and timolol for topical ophthalmic delivery and a method of treatment comprising administering said composition when indicated for glaucoma and associated conditions such as elevated intraocular pressure in the eyes of humans.
    Type: Grant
    Filed: October 14, 2003
    Date of Patent: January 22, 2008
    Assignee: Allergan, Inc.
    Inventors: Chin-Ming Chang, Gary J. Beck, Cynthia C. Pratt, Amy L. Batoosingh
  • Combination of brimonidine timolol for topical ophthalmic use
    Patent number: 7030149
    Abstract: Disclosed are pharmaceutical compositions comprising brimondine and timolol for topical ophthalmic delivery and a method of treatment comprising administering said composition when indicated for glaucoma and associated conditions such as elevated intraocular pressure in the eyes of humans.
    Type: Grant
    Filed: April 19, 2002
    Date of Patent: April 18, 2006
    Assignee: Allergan, Inc.
    Inventors: Chin-Ming Chang, Gary J. Beck, Cynthia C. Pratt, Amy L. Batoosingh
  • Preserved cyclodextrin-containing compositions
    Publication number: 20040175435
    Abstract: Compositions including a liquid medium, a cyclodextrin component and a preservative component which has a reduced tendency to being complexed with the cyclodextrin component. In one embodiment, the preservative component is a chlorite component. Active components, such as pharmaceutically active components or drugs, preferably are included in the compositions.
    Type: Application
    Filed: March 15, 2004
    Publication date: September 9, 2004
    Applicant: Allergan Sales, Inc.
    Inventors: Gary J. Beck, Edward D.S. Kerslake, Orest Olejnik
  • Combination of brimonidine and timolol for topical ophthalmic use
    Publication number: 20040102445
    Abstract: Disclosed are pharmaceutical compositions comprising brimondine and timolol for topical ophthalmic delivery and a method of treatment comprising administering said composition when indicated for glaucoma and associated conditions such as elevated intraocular pressure in the eyes of humans.
    Type: Application
    Filed: October 14, 2003
    Publication date: May 27, 2004
    Inventors: Chin-Ming Chang, Gary J. Beck, Cynthia C. Pratt, Amy L. Batoosingh
  • Preserved cyclodextrin-containing compositions
    Patent number: 6723353
    Abstract: Compositions including a liquid medium, a cyclodextrin component and a preservative component which has a reduced tendency to being complexed with the cyclodextrin component. In one embodiment, the preservative component is a chlorite component. Active components, such as pharmaceutically active components or drugs, preferably are included in the compositions.
    Type: Grant
    Filed: November 20, 2001
    Date of Patent: April 20, 2004
    Assignee: Allergan, Inc.
    Inventors: Gary J. Beck, Edward D. S. Kerslake, Orest Olejnik
  • Combination of brimonidine and timolol for topical ophthalmic use
    Publication number: 20030199507
    Abstract: Disclosed are pharmaceutical compositions comprising brimondine and timolol for topical ophthalmic delivery and a method of treatment comprising administering said composition when indicated for glaucoma and associated conditions such as elevated intraocular pressure in the eyes of humans.
    Type: Application
    Filed: February 3, 2003
    Publication date: October 23, 2003
    Inventors: Chin-Ming Chang, Gary J. Beck, Cynthia C. Pratt, Amy L. Batoosingh
  • Combination of brimonidine and timolol for topical ophthalmic use
    Publication number: 20030199509
    Abstract: Disclosed are pharmaceutical compositions comprising brimondine and timolol for topical ophthalmic delivery and a method of treatment comprising administering said composition when indicated for glaucoma and associated conditions such as elevated intraocular pressure in the eyes of humans.
    Type: Application
    Filed: April 19, 2002
    Publication date: October 23, 2003
    Inventors: Chin-Ming Chang, Gary J. Beck, Cynthia C. Pratt, Amy L. Batoosingh
  • Preserved cyclodextrin-containing compositions
    Publication number: 20020076449
    Abstract: Compositions including a liquid medium, a cyclodextrin component and a preservative component which has a reduced tendency to being complexed with the cyclodextrin component. In one embodiment, the preservative component is a chlorite component. Active components, such as pharmaceutically active components or drugs, preferably are included in the compositions.
    Type: Application
    Filed: November 20, 2001
    Publication date: June 20, 2002
    Applicant: Allergan Sales, Inc.
    Inventors: Gary J. Beck, Edward D.S. Kerslake, Orest Olejnik
  • Preserved cyclodextrin-containing compositions
    Patent number: 6358935
    Abstract: Compositions including a liquid medium, a cyclodextrin component and a preservative component which has a reduced tendency to being complexed with the cyclodextrin component. In one embodiment, the preservative component is a chlorite component. Active components, such as pharmaceutically active components or drugs, preferably are included in the compositions.
    Type: Grant
    Filed: September 2, 1999
    Date of Patent: March 19, 2002
    Assignee: Allergan Sales, Inc.
    Inventors: Gary J. Beck, Edward D. S. Kerslake, Orest Olejnik